Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rockstroh

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|December 5, 1997
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsG Fätkenheuer, A Theisen, J Rockstroh, et al.
European Journal of Medical Research|August 5, 2011
Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohortB Steffens, T Kümmerle, S Koch, et al.
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter studyM Hentrich, L Maretta, K U Chow, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
HIV Medicine|May 9, 2018
Scale-up of HIV self-testingS F Jakobsen, D Raben, I Sperle, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
HIV Medicine|August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysisM Murray, R S Hogg, V D Lima, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|December 5, 1997
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsG Fätkenheuer, A Theisen, J Rockstroh, et al.
European Journal of Medical Research|August 5, 2011
Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohortB Steffens, T Kümmerle, S Koch, et al.
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter studyM Hentrich, L Maretta, K U Chow, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
HIV Medicine|May 9, 2018
Scale-up of HIV self-testingS F Jakobsen, D Raben, I Sperle, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
HIV Medicine|August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysisM Murray, R S Hogg, V D Lima, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
Pageof 6